VitaDX

Last updated: February 24, 2024

Allan Rodriguez, CEO
Allan Rodriguez, CEO
Country: France | Funding: €4.7M (+)

Website: http://vitadx.com/en/

VitaDX is developing a non-invasive medical device for early detection of bladder cancer, based on a syndicate of French academic research.